<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-714X</journal-id>
<journal-title><![CDATA[Revista de la OFIL ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. OFIL·ILAPHAR]]></abbrev-journal-title>
<issn>1699-714X</issn>
<publisher>
<publisher-name><![CDATA[Organización de Farmacéuticos Ibero-Latinoamericanos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-714X2022000200013</article-id>
<article-id pub-id-type="doi">10.4321/s1699-714x2022000200013</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[¿Qué podemos aprender de los errores en el abordaje de la crisis opioides en Estados Unidos?]]></article-title>
<article-title xml:lang="en"><![CDATA[What can we learn from the errors in management of opioids epidemy in United States of America]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Regueras]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López-Guzmán]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Navarra  ]]></institution>
<addr-line><![CDATA[Pamplona Navarra]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<volume>32</volume>
<numero>2</numero>
<fpage>197</fpage>
<lpage>202</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-714X2022000200013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-714X2022000200013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-714X2022000200013&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La epidemia de opioides declarada en Estados unidos ha suscitado una profunda preocupación y polémica en torno al uso de estos fármacos. Aunque este problema no se ha extendido a Europa hasta el momento, se considera importante estudiar cuáles han podido ser los errores que se han cometido en Estados Unidos en el abordaje de esta epidemia. En este trabajo se identificaron cuatro errores respecto a las premisas adoptadas por los Estados Unidos para establecer la estrategia de lucha contra la epidemia: falta de adecuada identificación de las causas y el origen de la epidemia, error en la identificación de culpables, la mezcla de datos correspondientes a opioides de prescripción con los de opioides ilegales y una incorrecta cuantificación del problema. Como consecuencia de estos errores las soluciones y medidas aplicadas fueron ineficaces, tardías y estuvieron dirigidas a unos objetivos incorrectos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The opioids epidemic declared in the United States of America has generated a deep preoccupation and controversy in relation to the use of these drugs. Although this problem has not been extended to Europe until today, it seems relevant to analyze the errors that have been made by United States. In this article we have identified four errors related to the premises adopted by this country in the design of the strategy to fight the epidemic: inadequate identification of causes and origin of the epidemic, error in the identification of guilty, mixing of data related to prescription opioids and illegal opioids and an incorrect quantification of the problem. As consequence of these errors, the applied solutions and measures were inefficacious, late and were directed towards incorrect targets.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Opioides]]></kwd>
<kwd lng="es"><![CDATA[abuso]]></kwd>
<kwd lng="es"><![CDATA[epidemia]]></kwd>
<kwd lng="es"><![CDATA[errores]]></kwd>
<kwd lng="en"><![CDATA[Opioids]]></kwd>
<kwd lng="en"><![CDATA[abuse]]></kwd>
<kwd lng="en"><![CDATA[epidemic]]></kwd>
<kwd lng="en"><![CDATA[errors]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roehr]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trump declares opioid public health emergency but no extra money]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2017</year>
<volume>359</volume>
</nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gostin]]></surname>
<given-names><![CDATA[LO]]></given-names>
</name>
<name>
<surname><![CDATA[Hodge]]></surname>
<given-names><![CDATA[JG Jr]]></given-names>
</name>
<name>
<surname><![CDATA[Noe]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reframing the Opioid Epidemic as a National Emergency]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2017</year>
<volume>318</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>1539-40</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McCarthy]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[US declares opioid epidemic a national emergency]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2017</year>
<volume>358</volume>
<numero>14</numero>
<issue>14</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bonnie]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kesselheim]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2017</year>
<volume>318</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>423-4</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirson]]></surname>
<given-names><![CDATA[NY]]></given-names>
</name>
<name>
<surname><![CDATA[Scarpati]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Enloe]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Dincer]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Birnbaum]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[Mayne]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Economic Burden of Opioid Abuse: Updated Findings]]></article-title>
<source><![CDATA[J Manag Care Spec Pharm]]></source>
<year>2017</year>
<volume>23</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>427-45</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pollack]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[So Prescription Opioid Disorders are a $785 Billion Problem]]></article-title>
<source><![CDATA[Med Care]]></source>
<year>2016</year>
<volume>54</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>899-900</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mcneely]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Subramaniam]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Brady]]></surname>
<given-names><![CDATA[KT]]></given-names>
</name>
<name>
<surname><![CDATA[Vanveldhuisen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[DSM-5 substance use disorders among adult primary care patients: Results from a multisite study]]></article-title>
<source><![CDATA[Drug Alcohol Depend]]></source>
<year>2017</year>
<volume>179</volume>
<page-range>42-6</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Guidelines for the Use of Controlled Substances in the Treatment of Pain]]></article-title>
<source><![CDATA[New Hampshire Medical Society]]></source>
<year>1998</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="">
<collab>The Joint Commission</collab>
<source><![CDATA[Facts About Joint Commission Accreditation Standards for Healthcare Organizations: Pain Assessment and Management]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Viswanath]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Peck]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kaye]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Gill]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Simopoulos]]></surname>
<given-names><![CDATA[TT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A brief history of the opioid epidemic and strategies for pain medicine]]></article-title>
<source><![CDATA[Pain Ther]]></source>
<year>2018</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-21</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Joint Commission on Accreditation of Healthcare Organizations (JCAHO) Pain Management Standards Are Unveiled]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2000</year>
<volume>284</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>428-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="">
<collab>Food and Drug Administration</collab>
<source><![CDATA[Timeline of Selected FDA Activities and Significant Events Addressing Opioid Misuse and Abuse]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="">
<collab>Food and Drug Administration</collab>
<source><![CDATA[Abuse-Deterrent Opioid Analgesics]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="">
<source><![CDATA[National Drug Control Strategy]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comprehensive addiction and recovery act of 2016]]></article-title>
<source><![CDATA[America CUSo. congress.gov]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muhuri]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
<name>
<surname><![CDATA[Gfroerer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Associations of Nonmedical Pain Reliever Use and Initiation of Heroin use in the United States]]></article-title>
<source><![CDATA[CBHSQ Data Review, Center for behavioral health statistics and quality, SAMSHA]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="">
<collab>The president's commission on combating drug addiction and the opioid crisis</collab>
<source><![CDATA[The White House]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The SUPPORT for Patients and Communities Act - What Will It Mean for the Opioid-Overdose Crisis?]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2019</year>
<volume>380</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Portenoy]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Foley]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic use of opioid analgesics in non-malignant pain: report of 38 cases]]></article-title>
<source><![CDATA[Pain]]></source>
<year>1986</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>171-86</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Porter]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jick]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Addiction rare in patients treated with narcotics]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1980</year>
<volume>302</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B21">
<label>21.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zenz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Willweber-Strumpf]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Opiophobia and cancer pain in Europe]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1993</year>
<volume>341</volume>
<numero>8852</numero>
<issue>8852</issue>
<page-range>1075-6</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[APS 1995 Presidential address]]></article-title>
<source><![CDATA[Pain Forum]]></source>
<year>1996</year>
<volume>1</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>85-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23.</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comprehensive addiction and recovery act of 2016]]></article-title>
<source><![CDATA[America CUSo. congress.gov]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24.</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comprehensive addiction and recovery act of 2016. 114th Congress. 21st Century Cures Act]]></article-title>
<source><![CDATA[Public Law]]></source>
<year>2016</year>
<page-range>114-255</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rose]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Are prescription opioids driving the opioid crisis? Assumptions vs Facts]]></article-title>
<source><![CDATA[Pain Medicine]]></source>
<year>2018</year>
<volume>19</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>793-807</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26.</label><nlm-citation citation-type="">
<collab>Executive Office of Health and Human Services</collab>
<collab>Massachusetts Department of Public Health Current Statistics</collab>
<source><![CDATA[Data brief: Opioid-related over-dose deaths among Massachusetts residents]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B27">
<label>27.</label><nlm-citation citation-type="">
<source><![CDATA[FDA]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B28">
<label>28.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Howe]]></surname>
<given-names><![CDATA[CQ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Opioid therapy for chronic pain in the US: Promises and perils]]></article-title>
<source><![CDATA[Pain]]></source>
<year>2013</year>
<volume>154</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
<page-range>94-100</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scarpati]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Kirson]]></surname>
<given-names><![CDATA[NY]]></given-names>
</name>
<name>
<surname><![CDATA[Zichlin]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Jia]]></surname>
<given-names><![CDATA[ZB]]></given-names>
</name>
<name>
<surname><![CDATA[Birnbaum]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[Howard]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drivers of excess costs of opioid abuse among a commercially insured population]]></article-title>
<source><![CDATA[Am J Manag Care]]></source>
<year>2017</year>
<volume>23</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>276-82</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O'Rien]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Christrup]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Drewes]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Fallon]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Kress]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[McQuay]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[European Pain Federation position paper on appropriate opioid use in chronic pain management]]></article-title>
<source><![CDATA[Eur J Pain (United Kingdom)]]></source>
<year>2017</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-19</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31.</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Sanidad privada en España: 10,5 millones de asegurados y 5000 millones de ahorro al SNS]]></article-title>
<source><![CDATA[La Nueva España]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B32">
<label>32.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morone]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Weiner]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pain as the fifth vital sign: exposing the vital need for pain education]]></article-title>
<source><![CDATA[Clinical Therapeutics]]></source>
<year>2013</year>
<volume>35</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1728-32</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
